Molbio Diagnostics launches test to expand its Multi-Drug Resistant TB portfolio
By The Financial Express, January 12, 2023
https://www.financialexpress.com/healthcare/diagnostic/molbio-diagnostics-launches-test-to-expand-its-multi-drug-resistant-tb-portfolio/2946176/
Truenat MTB-INH is also expected to play a major role internationally, in high TB-burden countries as well as countries that already have a policy in place for INH testing on all TB-positive samples, it claimed.
Read moreMolbio Diagnostics placed 275th among India’s top 500 companies
By Navhind Times, December 05, 2022
https://www.navhindtimes.in/2022/12/05/magazines/bnc/molbio-diagnostics-placed-275th-among-indias-top-500-companies/
For the first time a Goan company Molbio Diagnostics, Verna figured among India’s 500 most valuable companies ranking published in the second edition of 2022 Burgundy Private Hurun India 500.
Read moreMolbio Diagnostics looking to expand test menu on its Truenat platform
Sohini Das, Business Standard, September 01, 2022
https://www.business-standard.com/article/companies/molbio-diagnostics-looking-to-expand-test-menu-on-its-truenat-platform-122083100814_1.html
Goa-based Molbio Diagnostics, which came up with a portable, battery operated RT-PCR point of care testing system that revolutionised India’s Covid-19 testing in the hinterland, is now planning to develop a plethora of tests to fuel its future growth
Read moreGoa showcases ‘Make in India’ for the World in Diagnostics -Largest Multi-Country Roll-Out of the Truenat® Technology for TB Diagnosis unveiled
Medicare News, August 25, 2022
https://medicarepharmabusiness.com/goa-showcases-make-in-india-for-the-world-in-diagnostics/
Goa based diagnostic company showcases its unique Truenat® Technology which is all set to come in handy for many countries in the elimination of Tuberculosis (TB). The hallmark of this technology is unprecedented maximum accuracy, duly endorsed by WHO (World Health Organization).
Read moreMolbio Diagnostics launches Truenat RT-PCR test for HIV 1/ HIV 2
By EH News Bureau, August 17, 2022, August 17, 2022
https://www.expresshealthcare.in/news/molbio-diagnostics-launches-truenat-rt-pcr-test-for-hiv-1-hiv-2/436021/
Molbio Diagnostics has launched a new test for differential diagnosis of HIV 1 and HIV 2 with viral loads within 60 minutes. The test works on the existing Truelab infrastructure and will require no additional set-ups and equipment
Read moreHepatitis: Will New Evidence For "same-day Test And Treat" Be A Game-changer?
CNS, August 15,2022, August 15, 2022
https://www.scoop.co.nz/stories/WO2208/S00090/hepatitis-will-new-evidence-for-same-day-test-and-treat-be-a-game-changer.htm
Those who were found positive for hepatitis C antibody, were offered the viral load test (Molbio TrueNat point-of-care nucleic acid amplification test), and those who were eligible for treatment as per the national guidelines, were initiated on sofosbuvir and daclastasvir on the same day.
Read moreResearch Publication: Truenat: An affordable and user-friendly option for screening of sub-microscopic Plasmodium infections in low resource countries
The Lancet Regional Health - Southeast Asia 2022;00: 100032 Published online xxx https://doi.org/10.1016/j. lansea.2022.100032, July 14, 2022
https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(22)00042-7/fulltext
Truenat may produce substantial benefits in identifying sub-microscopic Plasmodium infections in low resource settings due to its easy operations and cost-effectiveness. For successful elimination of SMI in India, demarcation of SMI hotspots by microscopy and Truenat supported with effective treatment would be a cost effective and more robust approach
Read moreResearch Publication -Validation of micro-chip based PCR assays for diagnosis of both Plasmodium falciparum and Plasmodium vivax
Journal of Vector Borne Diseases. 2022 Jan-Mar;59(1):57-62. doi: 10.4103/0972-9062.328978. PMID: 35708405., July 14, 2022
https://www.researchgate.net/publication/361189499_Validation_of_micro-chip_based_PCR_assays_for_diagnosis_of_both_Plasmodium_falciparum_and_Plasmodium_vivax
Based on high accuracy and precision between different lots, the Truenat® Malaria Pv-Pf and Pf assays were found to be suitable for the diagnosis of sub-microscopic infections in field conditions to provide support in elimination of malaria
Read moreBhubaneswar’s AIPH University Hosts Dengue Awareness Programmes
Odisha Bytes, July 08, 2022
https://odishabytes.com/bhubaneswars-aiph-university-hosts-dengue-awareness-programmes/
There was a live demonstration on sample testing of dengue-infected blood at the workshop. The students of AIPH University got hands-on experience of testing blood samples of dengue-infected patients using advanced TruNat machine, which was facilitated by Molbio Diagnostics
Read moreResearch Paper Published - A One Man Army- TrueNat Testing for the Identification of COVID-19 in Firozabad, Uttar Pradesh, India
Journal of Clinical and Diagnostic Research ; 16(5):DC01-DC05, 2022., July 05, 2022
https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1863306?lang=en
The Coronavirus Disease 2019 (COVID-19) pandemic has affected the entire world. The need of timely detection of the virus has been of prime importance and the efforts to develop sensitive, specific, rapid, portable and cost effective diagnostic methods promoted the indigenous development of TrueNat testing for viral load in COVID-19 detection which had been previously designed for detection of Tuberculosis and other infectious organisms.
Read more
